Neuroimmunology
Management of multiple sclerosis in COVID-19 pandemic
Oct. 03, 2023
This is an image preview.
Start a Free Account
to view the full image.
-
Nearly 3,000 illustrations, including video clips of neurologic disorders.
-
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
-
Full spectrum of neurology in 1,200 comprehensive articles.
-
Listen to MedLink on the go with Audio versions of each article.
Adults tested with high blood lead levels in 27 states
Total number of adults tested and whose blood lead levels (BLLs) were 25 µg/dL or higher, by quarter. From 27 states participating in the Adult Blood Lead Epidemiology and Surveillance (ABLES) Program, United States, 1997-1998.
Notes:
(1) Persons aged 16 to 64 years, categorized according to the highest reported BLL for that person during the given quarter. Second and third quarters of 1998 were not available for New Mexico; the corresponding 1997 quarters were used as estimates.
(2) The reporting threshold varies among the participating states; the value includes persons with BLLs lower than 25 µg/dL. However, the following states do not report persons with BLLs lower than 25 µg/dL: Maryland, Massachusetts, New Jersey, North Carolina, and Oregon. (3) Alabama, Arizona, Connecticut, Iowa, Maine, Maryland, Massachusetts, Minnesota, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Texas, Utah, Vermont, Washington, Wisconsin, and Wyoming.
(Source: Centers for Disease Control and Prevention. Adult Blood Lead Epidemiology and Surveillance--United States, second and third quarters, 1998, and annual 1994-1997. MMWR Morb Mortal Wkly Rep 1999;48[10]:213-6, 223. Public domain.)